PURPOSE: To assess if the treatment and control of hypertension aggregates in families. METHODS: The Genetic Epidemiology Network of Arteriopathy (GENOA) study enrolled sibships between 1997 and 1999, including 1329 hypertensive non-Hispanic blacks (1057 sibling pairs) from Jackson, Mississippi, 1133 hypertensive non-Hispanic whites (859 sibling pairs) from Rochester, Minnesota, and 752 hypertensive Hispanic whites (627 sibling pairs) from Starr County, Texas. Hypertension awareness and drug treatment were ascertained at examination; control was defined by blood pressure levels <140/90 mm Hg. As a measure of familial aggregation, odds ratios were calculated to assess concordance between sibling pairs in the treatment and control of hypertension. RESULTS: Overall, 90.5% of subjects were aware of their hypertension; 90.6% of those who were aware were treated with antihypertensive drugs and 56.0% of those treated had their hypertension controlled. There was statistically significant sib-sib concordance in the treatment of hypertension (odds ratio [OR] = 1.61; 95% confidence interval [CI]: 1.25 to 2.47; P = 0.003) and in the control of drug-treated hypertension (OR = 1.51; 95% CI: 1.25 to 1.81; P <0.0001). CONCLUSION: These findings suggest that the treatment and control of hypertension aggregates in families.
PURPOSE: To assess if the treatment and control of hypertension aggregates in families. METHODS: The Genetic Epidemiology Network of Arteriopathy (GENOA) study enrolled sibships between 1997 and 1999, including 1329 hypertensive non-Hispanic blacks (1057 sibling pairs) from Jackson, Mississippi, 1133 hypertensive non-Hispanic whites (859 sibling pairs) from Rochester, Minnesota, and 752 hypertensive Hispanic whites (627 sibling pairs) from Starr County, Texas. Hypertension awareness and drug treatment were ascertained at examination; control was defined by blood pressure levels <140/90 mm Hg. As a measure of familial aggregation, odds ratios were calculated to assess concordance between sibling pairs in the treatment and control of hypertension. RESULTS: Overall, 90.5% of subjects were aware of their hypertension; 90.6% of those who were aware were treated with antihypertensive drugs and 56.0% of those treated had their hypertension controlled. There was statistically significant sib-sib concordance in the treatment of hypertension (odds ratio [OR] = 1.61; 95% confidence interval [CI]: 1.25 to 2.47; P = 0.003) and in the control of drug-treated hypertension (OR = 1.51; 95% CI: 1.25 to 1.81; P <0.0001). CONCLUSION: These findings suggest that the treatment and control of hypertension aggregates in families.
Authors: Andrew D Rule; Mariza de Andrade; Martha Matsumoto; Tom H Mosley; Sharon Kardia; Stephen T Turner Journal: Rheumatology (Oxford) Date: 2010-12-24 Impact factor: 7.580
Authors: Yan V Sun; Alicia K Smith; Karen N Conneely; Qiuzhi Chang; Weiyan Li; Alicia Lazarus; Jennifer A Smith; Lynn M Almli; Elisabeth B Binder; Torsten Klengel; Dorthie Cross; Stephen T Turner; Kerry J Ressler; Sharon L R Kardia Journal: Hum Genet Date: 2013-05-09 Impact factor: 4.132
Authors: Daniel Wegmann; Darren E Kessner; Krishna R Veeramah; Rasika A Mathias; Dan L Nicolae; Lisa R Yanek; Yan V Sun; Dara G Torgerson; Nicholas Rafaels; Thomas Mosley; Lewis C Becker; Ingo Ruczinski; Terri H Beaty; Sharon L R Kardia; Deborah A Meyers; Kathleen C Barnes; Diane M Becker; Nelson B Freimer; John Novembre Journal: Nat Genet Date: 2011-07-20 Impact factor: 38.330
Authors: Michael P Epstein; Richard Duncan; Erin B Ware; Min A Jhun; Lawrence F Bielak; Wei Zhao; Jennifer A Smith; Patricia A Peyser; Sharon L R Kardia; Glen A Satten Journal: Am J Hum Genet Date: 2015-03-19 Impact factor: 11.025
Authors: Jiaxuan Liu; Wei Zhao; Farah Ammous; Stephen T Turner; Thomas H Mosley; Xiang Zhou; Jennifer A Smith Journal: Epigenetics Date: 2019-03-14 Impact factor: 4.528
Authors: Stephen T Turner; Andrew D Rule; Gary L Schwartz; Iftikhar J Kullo; Thomas H Mosley; Clifford R Jack; Sharon L R Kardia; Eric Boerwinkle; Kent R Bailey Journal: J Hypertens Date: 2011-09 Impact factor: 4.844
Authors: Magalie S Leduc; Lawrence C Shimmin; Kathy L E Klos; Craig Hanis; Eric Boerwinkle; James E Hixson Journal: J Lipid Res Date: 2008-08-01 Impact factor: 5.922
Authors: John C Lieske; Stephen T Turner; Samuel N Edeh; Jennifer A Smith; Sharon L R Kardia Journal: Clin J Am Soc Nephrol Date: 2014-02-27 Impact factor: 8.237
Authors: Jan Bressler; Myriam Fornage; Craig L Hanis; Wen Hong Linda Kao; Cora E Lewis; Ruth McPherson; Robert Dent; Thomas H Mosley; Len A Pennacchio; Eric Boerwinkle Journal: BMC Med Genet Date: 2009-06-12 Impact factor: 2.103